Published by Josh White on 23rd March 2022
(Sharecast News) - Biopharmaceutical company Arecor Therapeutics announced on Wednesday that the United States Patent and Trademark Office has granted a patent protecting novel formulations of its proprietary insulin products, 'AT247' and 'AT278'.
URL: http://www.digitallook.com/dl/news/story/32553743/...